Clinical Trial

Effectiveness and Cost-effectiveness of VTE Prevention Strategies in Gynecological Surgery

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 6, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
Venous thromboembolism (VTE) is a highly preventable but potentially fatal complication following gynecological surgery. The Caprini risk assessment model is widely used, but real-world evidence evaluating the net clinical benefit and cost-effectiveness of different prophylaxis strategies (mechanical vs. pharmacological) in gynecological patients with Caprini score $\\ge$ 2 is still lacking. This study aims to evaluate the relative effectiveness of basic, mechanical, and pharmacological VTE prophylaxis strategies using a retrospective 1:3 matched nested case-control design. Furthermore, a decision tree model will be constructed to evaluate the incremental cost-effectiveness ratio (ICER) of these strategies to provide health economic evidence for optimizing VTE management pathways in gynecology
Trial Details
NCT Number NCT07455253
Lead Sponsor Affiliated Hospital of Nantong University
Collaborators: Nantong No. 1 People's Hospital, The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China
Conditions Venous Thromboembolism, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Gynecological Surgery
Enrollment 234 participants
Start Date 2025-11-10
Primary Completion 2026-05 (estimated)
Study Completion 2026-08-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-06